FDA Brief

Company record

Hims & Hers Health, Inc. dba Hims

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Hims & Hers Health, Inc. dba Hims.

Warning letters

  1. Hims & Hers Health, Inc. dba Hims

    FDA warns Hims that compounded semaglutide website claims are false or misleading and misbrand the drugs.

    High risk